Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study
Vaarwerk B, van der Lee J, Breunis W, Orbach D, Chisholm J, Cozic N, Jenney M, van Rijn R, McHugh K, Gallego S, Glosli H, Devalck C, Gaze M, Kelsey A, Bergeron C, Stevens M, Oberlin O, Minard‐Colin V, Merks J. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. Cancer 2017, 124: 1016-1024. PMID: 29211298, DOI: 10.1002/cncr.31157.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyChildChild, PreschoolDisease-Free SurvivalFemaleHumansInduction ChemotherapyInfantInternational CooperationMaleMedical OncologyMesenchymomaOutcome Assessment, Health CarePediatricsRetrospective StudiesRhabdomyosarcomaSocieties, MedicalConceptsFailure-free survivalCourses of chemotherapyOverall survivalRadiologic responseProgressive diseasePrognostic valueCox proportional hazards regression analysisEarly responseProportional hazards regression analysisAdjusted hazard ratioKaplan-Meier methodCR/PRHazards regression analysisEfficacy of chemotherapyCox proportional hazardsCurrent European guidelinesInduction chemotherapyOS ratesHazard ratioPrognostic impactPediatric patientsIII patientsChemotherapyResponse assessmentPatients